ArticleACS omega2026
Mixing Regime Controlled Kinetics of Amorphous Calcium Phosphate Formation and Transformation.
Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Calcium phosphate precipitation plays a central role in biomineralization processes and the design of biomaterials, with amorphous calcium phosphate (ACP) often acting as a transient precursor to more stable crystalline phases such as hydroxyapatite (HA). Despite extensive research, the mechanistic pathways of ACP formation and transformation remain only partially understood, as they are highly system-specific and sensitive to dynamic changes in solution chemistry. Here, in situ potentiometric monitoring, combining pH and calcium ion-selective electrode (Ca-ISE) measurements, is used to monitor ACP precipitation and transformation under different mixing regimes and in the presence of model additives. Complementary solid-phase characterization is employed to validate phase identity and composition. All systems followed a two-step ACP-mediated pathway, characterized by an initial metastable period followed by ACP precipitation and subsequent transformation to poorly crystalline HA. However, significant differences in kinetics were observed: the
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.